Lai C.-C.ARISTINE CHENGYU-TSUNG HUANGKUEI-PIN CHUNGMENG-RUI LEELiao C.-H.PO-REN HSUEH2021-09-172021-09-1720110095-1137https://www.scopus.com/inward/record.uri?eid=2-s2.0-80355137191&doi=10.1128%2fJCM.05355-11&partnerID=40&md5=2f1b57a21a784a4d3173d3a289b3d4eahttps://scholars.lib.ntu.edu.tw/handle/123456789/583126Although Escherichia fergusonii has been identified for decades, it has rarely been recovered from clinical specimens and its clinical significance remains unclear. We describe a case of E. fergusonii bacteremia in a diabetic patient with pancreatic cancer. The isolate was confirmed by three commercial identification systems and 16S rRNA gene sequence analysis. The patient's clinical condition gradually improved, and repeated blood cultures were negative after antibiotic treatment with an in vitro active agent (ceftriaxone). Copyright ? 2011, American Society for Microbiology. All Rights Reserved.[SDGs]SDG3amikacin; amoxicillin plus clavulanic acid; ampicillin; antibiotic agent; cefepime; ceftriaxone; cefuroxime; ciprofloxacin; gentamicin; imipenem; piperacillin plus tazobactam; RNA 16S; aged; antibiotic therapy; article; bacteremia; bacterium isolate; blood culture; case report; computer assisted tomography; diabetic patient; Escherichia; Escherichia coli infection; Escherichia fergusonii; gene sequence; human; in vitro study; Klebsiella pneumoniae; laboratory test; male; nonhuman; nucleotide sequence; pancreas cancer; physical examination; priority journal; Aged; Anti-Bacterial Agents; Bacteremia; Diabetes Complications; DNA, Bacterial; DNA, Ribosomal; Enterobacteriaceae Infections; Escherichia; Humans; Male; Pancreatic Neoplasms; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Treatment Outcome; Escherichia fergusoniijournal article10.1128/JCM.05355-11219180302-s2.0-80355137191